The present invention relates to tumors such as ovarian cancer, lung cancer, stomach cancer, breast cancer, liver cancer, pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, sarcoma, bile duct cancer, bladder cancer, kidney cancer, colon cancer, placental villous epithelial cancer, cervical cancer, testicular cancer and uterine cancer. Provided are antibodies useful as a medicament for treating and/or preventing diseases associated with cells expressing CLDN6, including diseases.본 발명은 난소암, 폐암, 위암, 유방암, 간암, 췌장암, 피부암, 악성 흑생종, 두부 및 경부암, 육종, 담관암, 방광암, 신장암, 결장암, 태반 융모상피암, 자궁경부암, 고환암 및 자궁암과 같은 종양 관련 질병을 포함하는, CLDN6를 발현하는 세포와 관련된 질병을 치료 및/또는 예방하기 위한 약제로서 유용한 항체를 제공한다.
